SCHEMBL27901411

SCHEMBL27901411

Nc1cccc2[nH]nc(C3CC3)c12

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ GAA P10253 2/20 0.46
▸ PDPK1 O15530 3/20 0.42
▸ MAP2K1 Q02750 2/20 0.39
▸ AXL P30530 1/20 0.39
▸ KDR P35968 6/20 0.38
▸ KIT P10721 4/20 0.38
▸ FLT3 P36888 4/20 0.38
▸ LCK P06239 3/20 0.36
▸ CSF1R P07333 3/20 0.36
▸ FGFR1 P11362 3/20 0.36
▸ ROCK1 Q13464 3/20 0.36
▸ MAPK8 P45983 3/20 0.36
▸ MAPK9 P45984 3/20 0.36
▸ AURKA O14965 3/20 0.36
▸ PRKACA P17612 2/20 0.36
▸ PLK4 O00444 2/20 0.36
▸ CDK1 P06493 2/20 0.36
▸ LYN P07948 2/20 0.36
▸ RPS6KB1 P23443 2/20 0.36
▸ CDK2 P24941 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5137240 0.79 SLC6A4 (0.40) GAAPDPK1MAP2K1AXLKDR
SCHEMBL31586483 0.76 GAA (0.38) GAAPDPK1MAP2K1AXLKDR
SCHEMBL628649 0.74 PDPK1 (0.66) GAAPDPK1MAP2K1AXLKDR
SCHEMBL30065304 0.74 PDPK1 (0.66) GAAPDPK1MAP2K1AXLKDR
SCHEMBL23536586 0.72 RET (0.36) MAP2K1KDRKITFLT3LCK
SCHEMBL24330092 0.71 HTR1A (0.41) DYRK1AMEN1POLBKMT2AMKNK2
SCHEMBL1172460 0.71 GAA (0.47) GAAPDPK1MAP2K1AXLKDR
SCHEMBL1172394 0.71 GAA (0.56) GAAPDPK1MAP2K1AXLKDR
SCHEMBL3057752 0.71 KDM4E (0.50) GAAPDPK1FGFR1AURKAFLT1
SCHEMBL10076075 0.71 KDR (0.47) GAAPDPK1MAP2K1AXLKDR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-102822170-A Substituted N-(1H-indazol-4-yl)imidazo[1, 2-a]pyridine-3- carboxamide compounds as cFMS inhibitors ARRAY BIOPHARMA INC 2012-12-12 — — CN disclosed
Send feedback